Medicine and Dentistry
Amputation
14%
Biopsy Technique
13%
Bleeding
19%
Cancer
25%
Chemoradiotherapy
13%
Colorectal Liver Metastasis
18%
Computer Assisted Tomography
15%
Connective Tissue Cancer
17%
Conservative Treatment
15%
Desmoid Tumor
14%
Diseases
46%
Drug Megadose
16%
Elderly Patient
13%
Familial Adenomatous Polyposis
13%
Granulocyte
18%
Hepatectomy
21%
Ileo-Anal Pouch
22%
Intraductal Papillary Mucinous Tumor
15%
Ischemia
20%
Laparoscopic Surgery
15%
Laparotomy
21%
Limb
24%
Limb Perfusion
37%
Lung
33%
Lymph Node
18%
Lymph Node Metastasis
19%
Malignant Neoplasm
25%
Melanoma
43%
Melphalan
27%
Metastatic Carcinoma
45%
Neoadjuvant Therapy
20%
Neoplasm
100%
Neutrophil
24%
Obstruction
19%
Overall Survival
31%
Pancreas Adenocarcinoma
18%
Pancreas Cancer
18%
Pancreas Islet Cell Tumor
13%
Pancreaticoduodenectomy
16%
Postoperative Complication
29%
Proctocolectomy
17%
Rectum Cancer
26%
Recurrent Disease
36%
Soft Tissue Sarcoma
31%
Surgeon
18%
Surgical Anastomosis
16%
Surgical Approach
18%
Thromboxane
18%
Thromboxane B2
21%
Tumor Necrosis Factor
41%
Keyphrases
After Surgery
13%
Amputation
16%
Chemotherapy
20%
Colorectal Cancer
20%
Colorectal Liver Metastases
18%
Desmoid Tumor
14%
Diapedesis
21%
High Dose
16%
Ileal Pouch-anal Anastomosis
24%
Interleukin-2
14%
Intraductal Papillary mucinous Neoplasm
17%
Ischemia
41%
Isolated Limb Perfusion
34%
Israel
26%
Leukocytes
15%
Leukotriene B4 (LTB4)
32%
Liver
18%
Lung
38%
Lung Injury
24%
Lymph
29%
Lymph Node Metastasis
16%
Malignant Melanoma
25%
Mean Pulmonary Artery Pressure (mPAP)
15%
Medical Center
17%
Melanoma
17%
Melphalan
26%
Metastasis
22%
Metastatic Melanoma
15%
Neoadjuvant
19%
Neoadjuvant Therapy
20%
Neutrophils
24%
Overall Survival
23%
Oxygen Radicals
18%
Pancreatic Ductal Adenocarcinoma
17%
Pancreaticoduodenectomy
14%
Polymorphonuclear Leukocytes
21%
Postoperative Complications
23%
Reperfusion
33%
Resection
24%
Restorative Proctocolectomy
16%
Retroperitoneal Sarcoma
18%
Risk Factors
19%
Sham
16%
Soft Tissue Sarcoma
17%
Surgical Approach
18%
Thromboxane
37%
Thromboxane B2 (TXB2)
31%
Tumor
50%
Tumor Necrosis Factor-α
45%
Vascular Permeability
15%